Press Releases for BSX

Press Releases
Myriad Genetics Elects Louise Phanstiel and Lawrence Best to Its Board of Directors
GHX Working With Hospitals and Suppliers to Enable Use of Industry Standard Location and Organization Identifiers in Transactions and Compliance With GLN Sunrise Date ; GHX Assisting With Pilots, Transaction Guides, User Groups and Development of Services
Boston Scientific Announces Schedule for European Society of Cardiology Congress
Boston Scientific to Webcast Conference Call Discussing Results of Landmark MADIT-CRT Trial
BenchmarkJournal.Com Free Analyst Review for HNZ, BMO, CTB, BSX, XRAY and YHOO
Ahead of the Bell: Sunwin International Neutraceuticals - August 19, 2009
Trimedyne Reports Its Financial Results for the Quarter and Nine Months Ended June 30, 2009
Angiotech Pharmaceuticals, Inc. Announces Financial Results for the Second Quarter Ended June 30, 2009
Boston Scientific to Participate in BMO Capital Markets Health Care Conference
Stock in Focus: Sunwin International Neutraceuticals - July 30, 2009
Boston Scientific Announces Election of Katharine Bartlett and Bruce Byrnes to Its Board of Directors
Boston Scientific Announces Results for Second Quarter Ended June 30, 2009
FDA Approves Boston Scientific's TAXUS(R) Liberte(R) Long Stent
Boston Scientific Announces European Approval for Its LATITUDE(R) Patient Management System
Boston Scientific to Webcast Conference Call Discussing Second Quarter Financial Results
Boston Scientific Announces Retirement of Jim Tobin and Appointment of Ray Elliott as New President and CEO
MADIT-CRT Trial Meets Primary Endpoint
Boston Scientific to Participate in Wachovia Conference
Boston Scientific's Urology/Gynecology Products Featured in Studies at International Urogynecological Association Annual Meeting
Cappella Inc. Secures $17.3 Million Series C Investment
Battle Road Research Expands Healthcare Coverage and Launches Blog
Boston Scientific's SpyGlass(R) Direct Visualization System Featured in Broad Range of Clinical Studies at Upcoming Digestive Disease Week(R)
FDA Clears Boston Scientific's SpyScope(R) Access and Delivery Catheter for Use in Endoscopic Procedures Throughout Pancreatico-Biliary System
Boston Scientific Announces Two Directors Leave Board as Burns Named CEO of Xerox and Johnson Confirmed as Under Secretary of Energy
FDA Approves Boston Scientific's Next-Generation TAXUS(R) Liberte(R) Atom(TM) Stent System
Boston Scientific Welcomes Results of Brain Aneurysm Clinical Trial
Boston Scientific Begins Clinical Trial for Next-Generation Nitinol Stent to Treat Iliac Artery Disease
SYNTAX Analysis Finds Treatment With TAXUS(R) Express2(R) Stent System More Cost Effective Than Bypass Surgery in Patients With Complex Coronary Artery Disease
Fitch Raises Boston Scientific's Rating Outlook to Positive
Trimedyne Reports Its Financial Results for the Quarter Ended March 31, 2009
SYNTAX Substudy Shows Positive Outcomes for Left Main Patients Treated With TAXUS(R) Express2(R) Stent System
Boston Scientific Launches Third-Generation Platinum Chromium Drug-Eluting Stent
Boston Scientific Welcomes Launch of Syntax Score Website
Boston Scientific to Participate in Piper Jaffray PCR Post-Op Summit
Boston Scientific Announces Schedule for EuroPCR 2009
Boston Scientific Data Show Real-World Survival Rates for Implantable Cardiac Device Patients Exceed Rates From Clinical Trials
New MADIT II Clinical Data Analysis Shows Long-Term Survival Benefit for Implantable Defibrillator Therapy
Boston Scientific to Donate Cardiac Rhythm Management Devices to Heartbeat International for Implantation in Needy Patients
Boston Scientific Announces European Approval and First Implants of New Defibrillation Lead System Designed to Simplify the Surgical Process
Journal of American College of Cardiology Article Reports Fewer Repeat Procedures With Boston Scientific's TAXUS(R) Liberte(R) Stent
Boston Scientific Welcomes Publication of HORIZONS AMI Trial Results in New England Journal of Medicine
Boston Scientific Announces Results For First Quarter Ended March 31, 2009
Boston Scientific Announces First Quarter Special Items - Apr 15 2009 7:54PM
Boston Scientific Announces First Quarter Special Items - Apr 15 2009 5:52PM
Beacon Equity Issues Trade Alerts on Medical Device Stocks: ABT, BSX, JNJ, BAX, HSP, ZMH
Zacks Analyst Blog Highlights: Pfizer Inc., Wyeth, Satyam Computer Services Ltd., Abbott Laboratories and Boston Scientific Inc.
Boston Scientific to Webcast Conference Call Discussing First Quarter Financial Results - Apr 6 2009 12:18PM
Appeals Court Affirms That J&J Stents Infringe Boston Scientific Patent; Claims Against TAXUS Liberte Dismissed
Boston Scientific Welcomes House Passage of National Pain Care Policy Act
Clinical Data Reinforce Safety and Efficacy of Boston Scientific's Two Drug- Eluting Stent Platforms
SYNTAX Analysis Finds Treatment With TAXUS(R) Express2(TM) Stents More Cost Effective Than Bypass Surgery in Many Patients With Complex Coronary Artery Disease
Boston Scientific Announces Schedule For ACC 2009
Standard and Poor's Raises Boston Scientific's Rating Outlook to Positive
ARC Extends Reach in Medical Device Market on New License Agreement with Boston Scientific
Boston Scientific Launches New Coronary Imaging Catheter
Zacks Bull & Bear of the Day Highlights: Boston Scientific, Patriot Capital, AIG, Citigroup and Morgan Stanley - Mar 18 2009 11:51PM
Zacks Bull & Bear of the Day Highlights: Boston Scientific, Patriot Capital, AIG, Citigroup and Morgan Stanley - Mar 18 2009 7:17AM
Zacks Analyst Blog Highlights: CNOOC Ltd., The Coca-Cola Company, Boston Scientific Corp., Abbott Laboratories and Sanmina-SCI
OrbusNeich Files Patent Infringement Lawsuit Against Boston Scientific
Research and Markets: Keep Abreast of Spain's Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2015
Research and Markets: China Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2015 Out Now
Moody's Raises Boston Scientific's Rating Outlook to Stable
Zimmerman Reed Announces Court Certifies Class Action in Boston Scientific Securities Lawsuit -- BSX
Boston Scientific to Participate in Cowen Health Care Conference
Boston Scientific Welcomes Committee Approval of the National Pain Care Policy Act
Celsion Reports Fourth Quarter and Full Year 2008 Financial Results
Boston Scientific Announces Election Of John Sununu To Its Board Of Directors
Boston Scientific Resolves Outstanding Litigation Matter, Finalizes Goodwill Impairment Charge
New England Journal of Medicine Publishes Results from Boston Scientific's Landmark SYNTAX(TM) Trial
Boston Scientific Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents
Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2008
Boston Scientific Announces Japanese Approval for TAXUS(R) Liberte(R) Drug-Eluting Stent System
Boston Scientific and Medtronic Reach Agreement on Patent Disputes
BenchmarkJournal.Com (Complimentary) Analyst Review for AGN, BSX, GFI and GG
Boston Scientific Awarded CRM Contract by Department of Veterans Affairs
Boston Scientific Announces Court Decision - Jan 15 2009 2:58PM
Hospitals, Healthcare Providers to Save With Premier Diagnostic, Interventional Radiology and Peripheral, Biliary Stent Agreements
Boston Scientific to Webcast Conference Call Discussing Fourth Quarter and 2008 Financial Results
Hospitals, Healthcare Providers to Save With Premier's Electrophysiology Products Agreements
Boston Scientific to Participate in JP Morgan Health Care Conference
Boston Scientific Acquires Labcoat Limited
Boston Scientific Initiates Carotid Stent Clinical Study
FDA Approves Boston Scientific's Express(R) SD Renal Stent System
BridgewaterEquity.Com Free Fundamental Sector &Amp; Market Research on COP, BSX, SGP and XTO
Boston Scientific to Participate in Piper Jaffray Health Care Conference
Intelect Medical Closes $11 Million in Funding from Boston Scientific and Greatbatch for Stroke and TBI Recovery Clinical Trials
FDA Approves Boston Scientific's Apex(TM) PTCA Dilatation Catheter
Boston Scientific Welcomes Passage of Federal Pain Care Legislation to Benefit Military Members and Veterans
UK's NICE Recommends Spinal Cord Stimulation for Patients with Chronic Neuropathic Pain
FDA Approves Boston Scientific's Carotid Artery Stent
Boston Scientific Announces Results for Third Quarter Ended September 30, 2008
GHX and Lawson Software Partner to Improve Purchasing Efficiency and Contract Compliance in Healthcare
SectorWatch.biz Issues MarketStats on NWCI, STJ, ERES, BEAT, MDT, and BSX
FINAL ANNOUNCEMENT: Medtech Insight/Windhover's Medical Device Investor Day Symposium and Investment In Innovation (In3) East Conference -- October 22-24, Boston, MA
HORIZONS AMI Trial Demonstrates Superior Outcomes with TAXUS(R) Drug-Eluting Stents in Heart Attack Patients
TAXUS OLYMPIA Registry Shows Excellent Outcomes for High-Risk Patients Treated with Second-Generation TAXUS(R) Liberte(R) Stent - Oct 15 2008 9:57AM
SYNTAX Data Show Comparable Safety for Complex Patients Treated with TAXUS(R) Express2(TM) Stents and Bypass Surgery
Boston Scientific Provides Comments Reinforcing Strength of Its Balance Sheet
Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter
InsiderScore.com Publishes Comprehensive List of Corporate Insiders with Pledged Securities